Navigation Links
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results
Date:11/19/2013

LONDON, Nov. 19, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announces its preliminary results for the fourth quarter and the year ended 30 September 2013.  

2013 HIGHLIGHTS:

  • Initial public offering on the NASDAQ Global Market completed in May 2013 raising total net proceeds before expenses of $30.7m (£19.8m)
  • Two U.S.-targeted Sativex® Phase 3 pivotal programs advanced in 2013
  • Cancer Pain: two pivotal Sativex Phase 3 trials in recruitment
  • First Phase 3 top-line results expected in H2 2014
  • Data intended to lead to a New Drug Application (NDA) filing with the U.S. Food and Drug Administration (FDA)
  • Multiple Sclerosis (MS): Phase 3 Investigational New Drug (IND) application opened with the FDA for Sativex in the treatment of MS spasticity
  • Special Protocol Assessment (SPA) to be requested prior to anticipated start of Phase 3 trial in 2014
  • All Sativex Phase 3 clinical trials targeted at FDA approval are fully funded by U.S. partner, Otsuka
  • Sativex U.S. patent position further strengthened through two additional U.S. Notices of Allowance
  • Sativex now approved in 22 countries (ex-U.S) as a treatment for MS spasticity
  • In-market sales by partners increased by 25%
  • Commercial launch in Italy in July 2013
  • Germany pricing agreement reached in September 2013
  • Recommendation for approval in France in October 2013
  • On-going commercial launches in planning over next 12 months
  • New Sativex data presented at ECTRIMS in October 2013
  • Expansion of epilepsy research program through commencement of a new orphan pediatric epilepsy program for Epidiolex® (
    '/>"/>

  • SOURCE GW Pharmaceuticals plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
    4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
    5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
    6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
    7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
    9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
    10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
    11. Avanir Pharmaceuticals To Present at Three Conferences In May
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... Sept. 22, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... initiated a phase I clinical trial in patients ... safety, tolerability, and immunogenicity of INO-3106. This immunotherapy ... most aerodigestive cancers. Aerodigestive cancers affect ... and parts of the esophagus and windpipe. The ...
    (Date:9/22/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... TUV-SUD and The Medicinal Evaluation Board of ... its request for a label expansion for Neutrolin, ... in July 2013 for use in the prevention ...
    (Date:9/22/2014)... 2014  Seres Health, a clinical-stage therapeutics company developing ... today announced that it has been named by ... companies, designating it as one of the most promising ... "Amid a great deal of ain,t-it-cool science in microbiomics, ... to practical therapeutic development," says Damian Garde , ...
    Breaking Medicine Technology:Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
    ... BALTIMORE, Feb. 4, 2011 Ameritox®, the nation,s ... to advance its industry leadership position by strengthening ... the past twelve months.  Through significant investments in ... capabilities, Ameritox has reached several milestones – including ...
    ... R.I., Feb. 4, 2011 MEDfx Corporation today announced ... among providers using a combination of the standards and ... CONNECT Gateway. MEDfx is participating in, and is a ... of the National Coordinator of Health IT.  The MEDfx ...
    Cached Medicine Technology:Ameritox® Continues to Advance Industry Leadership 2Ameritox® Continues to Advance Industry Leadership 3Ameritox® Continues to Advance Industry Leadership 4MEDfx to Harmonize the Direct Project With CONNECT 2MEDfx to Harmonize the Direct Project With CONNECT 3
    (Date:9/22/2014)... a very familiar "lub-dub" pattern that speeds up or ... pattern itself isn,t as regular as you might think. ... vary even at a "constant" heart rateand that variability, ... Reduced heart rate variability (HRV) has been found to ... congestive heart failure and inflammation. For athletes, a drop ...
    (Date:9/22/2014)... 22, 2014 WHO: LiveOps, Inc., ... customer service solutions. , WHAT: The 10th annual ... customer care for the connected consumer. Constant change ... offer new challenges and opportunities for customer experience ... identify best practices, network and learn from fellow ...
    (Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... child,s brain processes sounds might help identify the severity ... Observing children,s brainwaves may also allow identification of autism ... "The finding that the brain,s response to certain ... hugely promising," said senior researcher Sophie Molholm, an associate ...
    (Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... California for a three-day conference to discuss brain-related ... brain injury from concussions and neurodegenerative disorders. ... medical director affiliated with a Silverado memory care ... of dedicated expertise in memory care, hosts the ...
    (Date:9/22/2014)... The report segments the global physiotherapy ... geography. The equipment segment accounted for a lion’s ... product. However, the accessories segment is expected to ... period, owing to the rising demand of physiotherapy ... segments are the fastest-growing segments in the physiotherapy ...
    Breaking Medicine News(10 mins):Health News:Variability keeps the body in balance 2Health News:Variability keeps the body in balance 3Health News:Variability keeps the body in balance 4Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5
    ... 4 BasicPlus Health,Insurance of Roswell, Ga., announced ... Companion Global Healthcare Inc. of Columbia, S.C., to,include ... most popular,limited benefit health insurance plans., The ... and BasicPlus (for individuals) limited benefit plans have ...
    ... outlines major issues and best practices for handling fresh, produce that every ... ... to know., ATLANTA, June 4 Fresh produce safety ... public awareness and,industry concern. At its biennial meeting in San Antonio, Texas, ...
    ... American Society for Investigative Pathology (ASIP) is pleased ... Professor of Pathology and Microbiology-Immunology at Northwestern University ... Amgen Outstanding Investigative Award, a prestigious annual award ... Amgen. Dr. Engman presented his paper, "Pathogenesis ...
    ... used chlorinated pesticides on more than 100 days in ... to researchers from the National Institutes of Health (NIH). ... from a 20 percent to a 200 percent increase ... Institute of Environmental Health Sciences (NIEHS) and the National ...
    ... LARGO, Fla., June 4 Unilens Vision ... UVI), which develops,licenses, manufactures, distributes and markets ... program for all Unilens GP (Gas Permeable),products., ... Professional,s Specialty Contact Lens,Company", continues its tradition ...
    ... 4th International Forum on Disability Management Will be Held in Berlin ... from 22 ... employees,capacity for work following sickness and disablement? Experts from,throughout the world will ... is to be held at the Berlin,Congress Centre from 22 to 24 ...
    Cached Medicine News:Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 2Health News:Insurance Company Includes Global Network Option in Limited Benefit Plans 3Health News:Chemstar Corporation Publishes New Insights on Fresh Produce Safety From CFP Workshop 2Health News:Long-term pesticide exposure may increase risk of diabetes 2Health News:Long-term pesticide exposure may increase risk of diabetes 3Health News:Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 2Health News:Retaining Employees' Capacity For Work Following Sickness 2
    ... a leading provider of immunofluorescence assays, with ... that includes kits for autoimmune diseases, infectious ... conjugates and components. Our Impact IFA Test ... substrates and kit sizes to choose from. ...
    ... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
    ... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
    ... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
    Medicine Products: